NCT05059678 Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor Diagnosis
| NCT ID | NCT05059678 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Metastatic Malignant Solid Neoplasm |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2021-11-30 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2021-11-30 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial examines the acceptability and effect of a parenting support intervention for families coping with solid tumor that has spread to other places in the body (metastatic) or has come back (recurrent). Parenting support program may help to reduce common parenting concerns, improve communication between parents and children about cancer, and improve the overall psychological wellbeing of parents.
Eligibility Criteria
Inclusion Criteria: * Participants must (1) be diagnosed with a metastatic or locally recurrent solid malignant tumor and on active treatment; (2) be at least 18 years old; (3) have at least one dependent child between the ages of 4 and 16 and currently living with the parent; (4) be able to provide informed consent and (5) have a spousal caregiver over the age of 18 who co-parents the child(ren) (i.e. share custody) and is willing and able to consent to participate.\* Exclusion Criteria: * Participants and caregivers who do not read and speak English and who do not have access to the internet.
Contact & Investigator
Kathrin Milbury
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT05059678 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Metastatic Malignant Solid Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05059678 currently recruiting?
Yes, NCT05059678 is actively recruiting participants. Contact the research team at kmilbury@mdanderson.org for enrollment information.
Where is the NCT05059678 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT05059678 clinical trial?
NCT05059678 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Kathrin Milbury at M.D. Anderson Cancer Center. The trial plans to enroll 120 participants.